AHCLNSEAnlon Healthcare LimitedLowNeutral
Announced Thu, 16 Apr · 13:10 IST

Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on April 16, 2026.

Board & Shareholder Meetings View source PDF

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.9%1-day move
₹13.88
prior close
₹14.05
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.2+0.1-0.1+1.9+4.4+1.8+4.8+4.0+2.7+0.9-1.4+16.2+9.9
Up moveDown movePending
AI summary

Anlon Healthcare's board has approved the acquisition of 1,11,00,000 equity shares (63.98%) in Remember India Health Links Private Limited for Rs. 5,38,12,800 in cash. Upon completion, the target company will become a subsidiary of Anlon Healthcare. Remember India Health Links is engaged in manufacturing pharmaceutical finished products/formulations such as tablets and capsules. Its turnover for FY 2024-25 stood at Rs. 83.08 lakh, down from Rs. 169.83 lakh in FY 2023-24. The acquisition is expected to be completed within 4-5 months from the signing date of the share purchase agreement dated April 16, 2026. The deal is not a related party transaction.

Likely market impact

This acquisition positions Anlon Healthcare to shift from being an API (drug substance) manufacturer to a complete pharmaceutical provider covering both APIs and finished dosage formulations (FDFs), with access to over 30 dossiers. This strategic expansion could be positive for the company's long-term revenue prospects and market positioning.